ZIMI LIMITED — Capital/Financing Update 2017

Feb 28, 2017

==> picture [252 x 70] intentionally omitted <==

1 March 2017

ASX Market Announcements ASX Limited 20 Bridge Street SYDNEY NSW 2000

ACQUISITION OF QUANTIFY TECHNOLOGY LIMITED - UPDATE

Quantify Technology Holdings Limited (ACN 113 326 524) ( Quantify or the Company ) (formerly WHL Energy Limited) is pleased to announce that the acquisition of Quantify Technology Limited (ACN 160 392 898) has been completed.

An Appendix 3B for the issue of securities from the Company’s successful $5,000,000 capital raising and acquisition of Quantify Technology Limited is attached.

As part of the completion process:

1. The change of name from WHL Energy Limited to Quantify Technology Holdings Limited has taken effect;

2. Mr Mark Lapins, Mr Aidan Montague and Mr Alex Paior have been appointed as directors of the Company; and

3. Mr Gary Castledine, Mr Faldi Ismail and Mr Neville Bassett have resigned as directors of the Company.

The Company is currently finalising all matters for reinstatement to official quotation.

The Company’s ASX ticker code has changed from WHN to QFY.

Yours faithfully N J Bassett Company Secretary

Quantify Technology Holdings Ltd ABN: 25 113 326 524 Registered Office: Level 4, 216 St Georges Terrace, Perth WA 6000 Postal Address: P.O. Box 7135, Perth WA 6850

T: +61 8 6268 2622 F: +61 8 6268 2699

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Quantify Technology Holdings Limited (Formerly WHL Energy Limited)

ABN

25 113 326 524

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued	A. Ordinary fully paid shares B. Options (30/9/19; $0.075) C. Options (30/9/19; $0.09) D. Performance Shares E. Founder Performance Shares F. Performance Rights
	A. 355,993,452 B. 73,236,165 C. 8,747,626 D. 120,000,000 E. 30,000,000 F. 12,500,000

• See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

3 Principal terms of the+securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

A. Fully paid ordinary B. Options exercisable at $0.075 each on or before 30 September 2019 C. Options exercisable at $0.09 each on or before 30 September 2019 D. Performance Shares issued in 4 tranches expiring within 54 months of reinstatement to official quotation, converting to ordinary shares on achievement of specified milestones, and otherwise on the terms and conditions contained in Schedule 1 of the Notice of Meeting lodged with ASX on 31 October 2016. E. Founder Performance Shares issued in 2 tranches expiring 18 months from reinstatement to official quotation, converting to ordinary shares on achievement of specified milestones, and otherwise on the terms and conditions contained in Schedule 3 of the Notice of Meeting lodged with ASX on 31 October 2016. F. Performance Rights issued in 2 tranches expiring 7 years from date of grant, converting to ordinary shares on achievement of specified milestones, and otherwise on the terms and conditions contained in Section 20.5(e) and Schedule 6 of the Notice of Meeting lodged with ASX on 31 October 2016.

• See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

4 Do the+securities rank equally in all respects from the+issue date with an existing+class of quoted +securities? If the additional+securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration	A. Yes B. No – Shares issued on exercise of options will rank equally with the existing shares of the Company. C. No – Shares issued on exercise of options will rank equally with the existing shares of the Company. D. No – Shares issued on conversion of Performance Shares will rank equally with the existing shares of the Company. E. No – Shares issued on conversion of Founder Performance Shares will rank equally with the existing shares of the Company. F. No – Shares issued on conversion of Performance Rights will rank equally with the existingshares of the Company.
	A. $0.06 94,166,666 ordinary shares Nil 261,826,786 ordinary shares issued as part consideration for the acquisition of Quantify Technology Ltd. B. Nil 68,236,165 Options issued as part consideration for the acquisition of Quantify Technology Ltd. Nil 5,000,000 Options issued as part consideration of capital raising fees. C. $0.001 8,747,626 Options issued for cash consideration of $0.001 each and in satisfaction of fees payable to corporate advisers. D. Nil 120,000,000 Performance Shares issued as part consideration for the acquisition of Quantify Technology Ltd. E. Nil 30,000,000 Founder Performance Shares as part consideration for the acquisition of Quantify Technology Ltd. F. Nil 12,500,000 Performance Rights issued as part of remuneration pursuant to the Performance Rights Plan

• See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution under rule 7.1A was passed 6c Number of +securities issued without security holder approval under rule 7.1 6d Number of+securities issued with security holder approval under rule 7.1A 6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of+securities issued under an exception in rule 7.2 6g If+securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.	Issued pursuant to Prospectus dated 23 December 2016, Bidder Statement dated 8 November 2016 and private agreements for the purpose of acquiring all of the issued capital of Quantify Technology Ltd, to re-comply with Chapters 1 and 2 of the ASX Listing Rules and to raise funds for the business operations of Quantify. Refer section 5 for further particulars.
	No
	N/A
	-
	-
	-
	-
	-

• See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Appendix 3B New issue announcement

6h If[+] securities were issued under - rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining Listing Rule 7.1 – 63,186,347 issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates 28 February 2017 Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. Number +Class 8 Number and +class of all 273,724,883 Ordinary shares +securities quoted on ASX ( including the[+] securities in section 7,329,965 Options ($0.166; 30 2 if applicable) June 2018)

• See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

9 Number and +class of all +securities not quoted on ASX (_including_the+securities in section 2 if applicable) 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)	Number	+Class
	133,342,563 13,774,619 880,585 1,320,875 232,539 4,216,905 8,747,626 31,596,511 41,639,654 62,115,701 57,884,299 30,000,000 12,500,000	Ordinary shares held in escrow for 24 months from reinstatement to official quotation. Ordinary shares held in escrow until 27 February 2018. Ordinary shares held in escrow until 14 March 2017. Ordinary shares held in escrow until 25 May 2017. Options exercisable at $11.62 on or before 3 December 2017. Options exercisable at $0.332 on or before 31 July 2018 Options exercisable at $0.09 on or before 30 September 2019 held in escrow for 24 months from reinstatement to official quotation. Options exercisable at $0.075 on or before 30 September 2019 held in escrow for 24 months from reinstatement to official quotation. Options exercisable at $0.075 on or before 30 September 2019 held in escrow until 27 February 2018. Performance Shares (1:1 ratio) held in escrow for 24 months from reinstatement to official quotation. Performance Shares (1:1 ratio) held in escrow until 27 February 2018. Founder Performance Shares (1:1 ratio) held in escrow for 24 months from reinstatement to official quotation. Performance Rights
	N/A

• See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B New issue announcement

Part 2 - Pro rata issue

art 2 - Pro rata issue
11 Is security holder approval required? 12 Is the issue renounceable or non- renounceable? 13 Ratio in which the+securities will be offered 14 +Class of+securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations	-
	-
	-
	-
	-
	-
	-
	-
	-

• See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

20 Names of any underwriters 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders 25 If the issue is contingent on security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and offer documents will be sent to persons entitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if applicable) 29 Date rights trading will end (if applicable) 30 How do security holders sell their entitlements_in full_through a broker? 31 How do security holders sell_part_of their entitlements through a broker and accept for the balance?	-
	-
	-
	-
	-
	-
	-
	-
	-
	-
	-
	-

• See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Appendix 3B New issue announcement

• 32 How do security holders dispose of their entitlements (except by sale through a broker)?

• 33 +Issue date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of[+] securities ( tick one )

• (a) +Securities described in Part 1

• (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

• 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

• 1 - 1,000

• 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

• 37 A copy of any trust deed for the additional[+] securities

• See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

• 38 Number of[+] securities for which - +quotation is sought

• 39 +Class of +securities for which - quotation is sought

• 40 Do the[+] securities rank equally in all - respects from the[+] issue date with an existing[+] class of quoted[+] securities? If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

• • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

• 41 Reason for request for quotation - now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security) Number +Class

• 42 Number and[+] class of all[+] securities - quoted on ASX ( including the +securities in clause 38)

• See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Appendix 3B New issue announcement

Quotation agreement

• 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

• 2 We warrant the following to ASX.

• The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

• There is no reason why those[+] securities should not be granted[+] quotation.

• An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

• If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: N J Bassett Date: 1 March 2017 (Company secretary)

Print name: Neville John Bassett

== == == == ==

• See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [415 x 403] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid [+] ordinary 66,815,133
securities on issue 12 months before the
+ issue date or date of agreement to issue
Add the following:
• Number of fully paid [+] ordinary securities Ordinary shares issued 28/2/17 355,993,452
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid [+] ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid [+] ordinary Nil
securities cancelled during that 12 month
period
“A” 422,808,585
----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”
“B”	0.15 [Note: this value cannot be changed]
Multiply“A” by 0.15	63,421,287
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used
Insertnumber of+equity securities issued or agreed to be issued in that 12 month period_not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items	Shares issued 29 June 2016 234,940
“C”	234,940
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1
“A” x 0.15 Note: number must be same as shown in Step 2	63,421,287
Subtract“C” Note: number must be same as shown in Step 3	234,940
Total[“A” x 0.15] – “C”	63,186,347 [Note: this is the remaining placement capacity under rule 7.1]

• See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” - Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed -

Multiply “A” by 0.10

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities – not just ordinary securities

• Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

“E” -

• See chapter 19 for defined terms.

Appendix 3B Page 14

04/03/2013

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 Note: number must be same as shown in Step 2	-
Subtract“E” Note: number must be same as shown in Step 3	-
Total[“A” x 0.10] – “E”	- Note: this is the remaining placement capacity under rule 7.1A

• See chapter 19 for defined terms.

Appendix 3B Page 15

04/03/2013